Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-11104-00969
Entry Name
UniProt Accession
Theoretical PI
8.53
Molecular Weight
327201.88
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
RNA-directed RNA polymerase
Protein Synonyms/Alias
Capsid protein C; p21; gp32; gp35; NS1; gp68; gp70; p23; 3.4.22.-; 3.4.21.98; 3.6.1.15; 3.6.4.13; Hepacivirin; NS3P; p70; NS4A; p8; NS4B; p27; NS5A; p56; 2.7.7.48; NS5B; p68;
Gene Name
Gene Synonyms/Alias
Created Date
01-AUG-1992
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
1968
Canonical
HQWISSECTTPCSGS
[1]
S-Palmitoylation
1972
Canonical
SSECTTPCSGSWLRD
[1]
S-Palmitoylation
Organism
Hepatitis C virus genotype 1a (isolate 1) (HCV)
NCBI Taxa ID
11104
Reference
[1] Yu GY, Lee KJ, Gao L, Lai MM. Palmitoylation and polymerization of hepatitis Cvirus NS4B protein. J Virol. 2006 Jun;80(12):6013-23.[PMID:16731940]
Functional Description
Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Thought to play a role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Could mediate apoptotic pathways through association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptor-induced apoptosis remains controversial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Seric core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. Alters lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage. Core protein induces up-regulation of FAS promoter activity, and thereby probably contributes to the increased triglyceride accumulation in hepatocytes (steatosis) (By similarity).
Sequence Annotation
Topological domain: 2 168 Cytoplasmic.
Transmembrane: 169 189 Helical.
Topological domain: 190 358 Lumenal.
Transmembrane: 359 379 Helical.
Topological domain: 380 725 Lumenal.
Transmembrane: 726 746 Helical.
Topological domain: 747 757 Lumenal.
Transmembrane: 758 778 Helical.
Topological domain: 779 782 Cytoplasmic.
Transmembrane: 783 803 Helical.
Topological domain: 804 813 Lumenal.
Transmembrane: 814 834 Helical.
Topological domain: 835 881 Cytoplasmic.
Transmembrane: 882 902 Helical.
Topological domain: 903 928 Lumenal.
Transmembrane: 929 949 Helical.
Topological domain: 950 1657 Cytoplasmic.
Transmembrane: 1658 1678 Helical.
Topological domain: 1679 1805 Cytoplasmic.
Transmembrane: 1806 1826 Helical.
Topological domain: 1827 1828 Lumenal.
Transmembrane: 1829 1849 Helical.
Topological domain: 1850 1850 Cytoplasmic.
Transmembrane: 1851 1871 Helical.
Topological domain: 1872 1881 Lumenal.
Transmembrane: 1882 1902 Helical.
Topological domain: 1903 1972 Cytoplasmic.
Topological domain: 2003 2990 Cytoplasmic.
Transmembrane: 2991 3011 Helical.
Domain: 899 1026 Peptidase C18.
Domain: 1217 1369 Helicase ATP-binding.
Domain: 2634 2752 RdRp catalytic.
Nucleotide-binding: 1230 1237 ATP.
Region: 2 59 Interaction with DDX3X.
Region: 2 23 Interaction with STAT1.
Region: 122 173 Interaction with APOA2.
Region: 150 159 Mitochondrial targeting signal.
Region: 164 167 Important for lipid dropletslocalization.
Region: 265 296 Fusion peptide.
Region: 385 411 HVR1.
Region: 475 481 HVR2.
Region: 482 494 CD81-binding 1.
Region: 522 553 CD81-binding 2.
Region: 660 671 PKR/eIF2-alpha phosphorylation homologydomain (PePHD).
Region: 1679 1690 NS3-binding (by NS4A).
Region: 2120 2332 Transcriptional activation.
Region: 2120 2208 FKBP8-binding.
Region: 2200 2250 Basal phosphorylation.
Region: 2210 2275 PKR-binding.
Region: 2249 2306 NS4B-binding.
Region: 2351 2420 Basal phosphorylation.
Region: 2354 2377 V3.
Motif: 5 13 Nuclear localization signal.
Motif: 38 43 Nuclear localization signal.
Motif: 58 64 Nuclear localization signal.
Motif: 66 71 Nuclear localization signal.
Motif: 1316 1319 DECH box.
Motif: 2322 2325 SH3-binding.
Motif: 2327 2335 Nuclear localization signal.
Active site: 952 952 For protease NS2-3 activity; shared withdimeric partner.
Active site: 972 972 For protease NS2-3 activity; shared withdimeric partner.
Active site: 993 993 For protease NS2-3 activity; shared withdimeric partner.
Active site: 1083 1083 Charge relay system; for serine proteaseNS3 activity.
Active site: 1107 1107 Charge relay system; for serine proteaseNS3 activity.
Active site: 1165 1165 Charge relay system; for serine proteaseNS3 activity.
Metal binding site: 1123 1123 Zinc.
Metal binding site: 1125 1125 Zinc.
Metal binding site: 1171 1171 Zinc.
Metal binding site: 1175 1175 Zinc.
Metal binding site: 2011 2011 Zinc.
Metal binding site: 2029 2029 Zinc.
Metal binding site: 2031 2031 Zinc.
Metal binding site: 2052 2052 Zinc.
Functional site: 177 178 Cleavage; by host signal peptidase.
Functional site: 191 192 Cleavage; by host signal peptidase.
Functional site: 383 384 Cleavage; by host signal peptidase.
Functional site: 746 747 Cleavage; by host signal peptidase.
Functional site: 809 810 Cleavage; by host signal peptidase.
Functional site: 1026 1027 Cleavage; by protease NS2-3.
Functional site: 1657 1658 Cleavage; by serine protease NS3.
Functional site: 1711 1712 Cleavage; by serine protease NS3.
Functional site: 1972 1973 Cleavage; by serine protease NS3.
Functional site: 2420 2421 Cleavage; by serine protease NS3.
Modified residue: 2 2 N-acetylserine; by host.
Modified residue: 53 53 Phosphoserine; by host.
Modified residue: 99 99 Phosphoserine; by host.
Modified residue: 116 116 Phosphoserine; by host PKA.
Modified residue: 2194 2194 Phosphoserine; by host; in p56.
Modified residue: 2197 2197 Phosphoserine; by host; in p58.
Modified residue: 2201 2201 Phosphoserine; by host; in p58.
Modified residue: 2204 2204 Phosphoserine; by host; in p58.
Modified residue: 2321 2321 Phosphoserine; by host.
Protein Length
3011 AA.
Protein Sequence
(Canonical)
MSTNPKPQKK NKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR KTSERSQPRG  60
RRQPIPKARR PEGRTWAQPG YPWPLYGNEG CGWAGWLLSP RGSRPSWGPT DPRRRSRNLG  120
KVIDTLTCGF ADLMGYIPLV GAPLGGAARA LAHGVRVLED GVNYATGNLP GCSFSIFLLA  180
LLSCLTVPAS AYQVRNSTGL YHVTNDCPNS SIVYEAADAI LHTPGCVPCV REGNASRCWV  240
AMTPTVATRD GKLPATQLRR HIDLLVGSAT LCSALYVGDL CGSVFLVGQL FTFSPRRHWT  300
TQGCNCSIYP GHITGHRMAW DMMMNWSPTT ALVMAQLLRI PQAILDMIAG AHWGVLAGIA  360
YFSMVGNWAK VLVVLLLFAG VDAETHVTGG SAGHTVSGFV SLLAPGAKQN VQLINTNGSW  420
HLNSTALNCN DSLNTGWLAG LFYHHKFNSS GCPERLASCR PLTDFDQGWG PISYANGSGP  480
DQRPYCWHYP PKPCGIVPAK SVCGPVYCFT PSPVVVGTTD RSGAPTYSWG ENDTDVFVLN  540
NTRPPLGNWF GCTWMNSTGF TKVCGAPPCV IGGAGNNTLH CPTDCFRKHP DATYSRCGSG  600
PWITPRCLVD YPYRLWHYPC TINYTIFKIR MYVGGVEHRL EAACNWTRGE RCDLEDRDRS  660
ELSPLLLTTT QWQVLPCSFT TLPALSTGLI HLHQNIVDVQ YLYGVGSSIA SWAIKWEYVV  720
LLFLLLADAR VCSCLWMMLL ISQAEAALEN LVILNAASLA GTHGLVSFLV FFCFAWYLKG  780
KWVPGAVYTF YGMWPLLLLL LALPQRAYAL DTEVAASCGG VVLVGLMALT LSPYYKRYIS  840
WCLWWLQYFL TRVEAQLHVW IPPLNVRGGR DAVILLMCAV HPTLVFDITK LLLAVFGPLW  900
ILQASLLKVP YFVRVQGLLR FCALARKMIG GHYVQMVIIK LGALTGTYVY NHLTPLRDWA  960
HNGLRDLAVA VEPVVFSQME TKLITWGADT AACGDIINGL PVSARRGREI LLGPADGMVS  1020
KGWRLLAPIT AYAQQTRGLL GCIITSLTGR DKNQVEGEVQ IVSTAAQTFL ATCINGVCWT  1080
VYHGAGTRTI ASPKGPVIQM YTNVDQDLVG WPAPQGSRSL TPCTCGSSDL YLVTRHADVI  1140
PVRRRGDSRG SLLSPRPISY LKGSSGGPLL CPAGHAVGIF RAAVCTRGVA KAVDFIPVEN  1200
LETTMRSPVF TDNSSPPVVP QSFQVAHLHA PTGSGKSTKV PAAYAAQGYK VLVLNPSVAA  1260
TLGFGAYMSK AHGIDPNIRT GVRTITTGSP ITYSTYGKFL ADGGCSGGAY DIIICDECHS  1320
TDATSILGIG TVLDQAETAG ARLVVLATAT PPGSVTVPHP NIEEVALSTT GEIPFYGKAI  1380
PLEVIKGGRH LIFCHSKKKC DELAAKLVAL GINAVAYYRG LDVSVIPTSG DVVVVATDAL  1440
MTGYTGDFDS VIDCNTCVTQ TVDFSLDPTF TIETITLPQD AVSRTQRRGR TGRGKPGIYR  1500
FVAPGERPSG MFDSSVLCEC YDAGCAWYEL TPAETTVRLR AYMNTPGLPV CQDHLEFWEG  1560
VFTGLTHIDA HFLSQTKQSG ENLPYLVAYQ ATVCARAQAP PPSWDQMWKC LIRLKPTLHG  1620
PTPLLYRLGA VQNEITLTHP VTKYIMTCMS ADLEVVTSTW VLVGGVLAAL AAYCLSTGCV  1680
VIVGRVVLSG KPAIIPDREV LYREFDEMEE CSQHLPYIEQ GMMLAEQFKQ KALGLLQTAS  1740
RQAEVIAPAV QTNWQKLETF WAKHMWNFIS GIQYLAGLST LPGNPAIASL MAFTAAVTSP  1800
LTTSQTLLFN ILGGWVAAQL AAPGAATAFV GAGLAGAAIG SVGLGKVLID ILAGYGAGVA  1860
GALVAFKIMS GEVPSTEDLV NLLPAILSPG ALVVGVVCAA ILRRHVGPGE GAVQWMNRLI  1920
AFASRGNHVS PTHYVPESDA AARVTAILSS LTVTQLLRRL HQWISSECTT PCSGSWLRDI  1980
WDWICEVLSD FKTWLKAKLM PQLPGIPFVS CQRGYKGVWR VDGIMHTRCH CGAEITGHVK  2040
NGTMRIVGPR TCRNMWSGTF PINAYTTGPC TPLPAPNYTF ALWRVSAEEY VEIRQVGDFH  2100
YVTGMTTDNL KCPCQVPSPE FFTELDGVRL HRFAPPCKPL LREEVSFRVG LHEYPVGSQL  2160
PCEPEPDVAV LTSMLTDPSH ITAEAAGRRL ARGSPPSVAS SSASQLSAPS LKATCTANHD  2220
SPDAELIEAN LLWRQEMGGN ITRVESENKV VILDSFDPLV AEEDEREISV PAEILRKSRR  2280
FAQALPVWAR PDYNPPLVET WKKPDYEPPV VHGCPLPPPK SPPVPPPRKK RTVVLTESTL  2340
STALAELATR SFGSSSTSGI TGDNTTTSSE PAPSGCPPDS DAESYSSMPP LEGEPGDPDL  2400
SDGSWSTVSS EANAEDVVCC SMSYSWTGAL VTPCAAEEQK LPINALSNSL LRHHNLVYST  2460
TSRSACQRQK KVTFDRLQVL DSHYQDVLKE VKAAASKVKA NLLSVEEACS LTPPHSAKSK  2520
FGYGAKDVRC HARKAVTHIN SVWKDLLEDN VTPIDTTIMA KNEVFCVQPE KGGRKPARLI  2580
VFPDLGVRVC EKMALYDVVT KLPLAVMGSS YGFQYSPGQR VEFLVQAWKS KKTPMGFSYD  2640
TRCFDSTVTE SDIRTEEAIY QCCDLDPQAR VAIKSLTERL YVGGPLTNSR GENCGYRRCR  2700
ASGVLTTSCG NTLTCYIKAR AACRAAGLQD CTMLVCGDDL VVICESAGVQ EDAASLRAFT  2760
EAMTRYSAPP GDPPQPEYDL ELITSCSSNV SVAHDGAGKR VYYLTRDPTT PLARAAWETA  2820
RHTPVNSWLG NIIMFAPTLW ARMILMTHFF SVLIARDQLE QALDCEIYGA CYSIEPLDLP  2880
PIIQRLHGLS AFSLHSYSPG EINRVAACLR KLGVPPLRAW RHRARSVRAR LLARGGRAAI  2940
CGKYLFNWAV RTKLKLTPIA AAGQLDLSGW FTAGYSGGDI YHSVSHARPR WIWFCLLLLA  3000
AGVGIYLLPN R                                                       3011
FASTA
(Canonical)
>LipidDB-11104-00969|P26664
MSTNPKPQKKNKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRG
RRQPIPKARRPEGRTWAQPGYPWPLYGNEGCGWAGWLLSPRGSRPSWGPTDPRRRSRNLG
KVIDTLTCGFADLMGYIPLVGAPLGGAARALAHGVRVLEDGVNYATGNLPGCSFSIFLLA
LLSCLTVPASAYQVRNSTGLYHVTNDCPNSSIVYEAADAILHTPGCVPCVREGNASRCWV
AMTPTVATRDGKLPATQLRRHIDLLVGSATLCSALYVGDLCGSVFLVGQLFTFSPRRHWT
TQGCNCSIYPGHITGHRMAWDMMMNWSPTTALVMAQLLRIPQAILDMIAGAHWGVLAGIA
YFSMVGNWAKVLVVLLLFAGVDAETHVTGGSAGHTVSGFVSLLAPGAKQNVQLINTNGSW
HLNSTALNCNDSLNTGWLAGLFYHHKFNSSGCPERLASCRPLTDFDQGWGPISYANGSGP
DQRPYCWHYPPKPCGIVPAKSVCGPVYCFTPSPVVVGTTDRSGAPTYSWGENDTDVFVLN
NTRPPLGNWFGCTWMNSTGFTKVCGAPPCVIGGAGNNTLHCPTDCFRKHPDATYSRCGSG
PWITPRCLVDYPYRLWHYPCTINYTIFKIRMYVGGVEHRLEAACNWTRGERCDLEDRDRS
ELSPLLLTTTQWQVLPCSFTTLPALSTGLIHLHQNIVDVQYLYGVGSSIASWAIKWEYVV
LLFLLLADARVCSCLWMMLLISQAEAALENLVILNAASLAGTHGLVSFLVFFCFAWYLKG
KWVPGAVYTFYGMWPLLLLLLALPQRAYALDTEVAASCGGVVLVGLMALTLSPYYKRYIS
WCLWWLQYFLTRVEAQLHVWIPPLNVRGGRDAVILLMCAVHPTLVFDITKLLLAVFGPLW
ILQASLLKVPYFVRVQGLLRFCALARKMIGGHYVQMVIIKLGALTGTYVYNHLTPLRDWA
HNGLRDLAVAVEPVVFSQMETKLITWGADTAACGDIINGLPVSARRGREILLGPADGMVS
KGWRLLAPITAYAQQTRGLLGCIITSLTGRDKNQVEGEVQIVSTAAQTFLATCINGVCWT
VYHGAGTRTIASPKGPVIQMYTNVDQDLVGWPAPQGSRSLTPCTCGSSDLYLVTRHADVI
PVRRRGDSRGSLLSPRPISYLKGSSGGPLLCPAGHAVGIFRAAVCTRGVAKAVDFIPVEN
LETTMRSPVFTDNSSPPVVPQSFQVAHLHAPTGSGKSTKVPAAYAAQGYKVLVLNPSVAA
TLGFGAYMSKAHGIDPNIRTGVRTITTGSPITYSTYGKFLADGGCSGGAYDIIICDECHS
TDATSILGIGTVLDQAETAGARLVVLATATPPGSVTVPHPNIEEVALSTTGEIPFYGKAI
PLEVIKGGRHLIFCHSKKKCDELAAKLVALGINAVAYYRGLDVSVIPTSGDVVVVATDAL
MTGYTGDFDSVIDCNTCVTQTVDFSLDPTFTIETITLPQDAVSRTQRRGRTGRGKPGIYR
FVAPGERPSGMFDSSVLCECYDAGCAWYELTPAETTVRLRAYMNTPGLPVCQDHLEFWEG
VFTGLTHIDAHFLSQTKQSGENLPYLVAYQATVCARAQAPPPSWDQMWKCLIRLKPTLHG
PTPLLYRLGAVQNEITLTHPVTKYIMTCMSADLEVVTSTWVLVGGVLAALAAYCLSTGCV
VIVGRVVLSGKPAIIPDREVLYREFDEMEECSQHLPYIEQGMMLAEQFKQKALGLLQTAS
RQAEVIAPAVQTNWQKLETFWAKHMWNFISGIQYLAGLSTLPGNPAIASLMAFTAAVTSP
LTTSQTLLFNILGGWVAAQLAAPGAATAFVGAGLAGAAIGSVGLGKVLIDILAGYGAGVA
GALVAFKIMSGEVPSTEDLVNLLPAILSPGALVVGVVCAAILRRHVGPGEGAVQWMNRLI
AFASRGNHVSPTHYVPESDAAARVTAILSSLTVTQLLRRLHQWISSECTTPCSGSWLRDI
WDWICEVLSDFKTWLKAKLMPQLPGIPFVSCQRGYKGVWRVDGIMHTRCHCGAEITGHVK
NGTMRIVGPRTCRNMWSGTFPINAYTTGPCTPLPAPNYTFALWRVSAEEYVEIRQVGDFH
YVTGMTTDNLKCPCQVPSPEFFTELDGVRLHRFAPPCKPLLREEVSFRVGLHEYPVGSQL
PCEPEPDVAVLTSMLTDPSHITAEAAGRRLARGSPPSVASSSASQLSAPSLKATCTANHD
SPDAELIEANLLWRQEMGGNITRVESENKVVILDSFDPLVAEEDEREISVPAEILRKSRR
FAQALPVWARPDYNPPLVETWKKPDYEPPVVHGCPLPPPKSPPVPPPRKKRTVVLTESTL
STALAELATRSFGSSSTSGITGDNTTTSSEPAPSGCPPDSDAESYSSMPPLEGEPGDPDL
SDGSWSTVSSEANAEDVVCCSMSYSWTGALVTPCAAEEQKLPINALSNSLLRHHNLVYST
TSRSACQRQKKVTFDRLQVLDSHYQDVLKEVKAAASKVKANLLSVEEACSLTPPHSAKSK
FGYGAKDVRCHARKAVTHINSVWKDLLEDNVTPIDTTIMAKNEVFCVQPEKGGRKPARLI
VFPDLGVRVCEKMALYDVVTKLPLAVMGSSYGFQYSPGQRVEFLVQAWKSKKTPMGFSYD
TRCFDSTVTESDIRTEEAIYQCCDLDPQARVAIKSLTERLYVGGPLTNSRGENCGYRRCR
ASGVLTTSCGNTLTCYIKARAACRAAGLQDCTMLVCGDDLVVICESAGVQEDAASLRAFT
EAMTRYSAPPGDPPQPEYDLELITSCSSNVSVAHDGAGKRVYYLTRDPTTPLARAAWETA
RHTPVNSWLGNIIMFAPTLWARMILMTHFFSVLIARDQLEQALDCEIYGACYSIEPLDLP
PIIQRLHGLSAFSLHSYSPGEINRVAACLRKLGVPPLRAWRHRARSVRARLLARGGRAAI
CGKYLFNWAVRTKLKLTPIAAAGQLDLSGWFTAGYSGGDIYHSVSHARPRWIWFCLLLLA
AGVGIYLLPNR
Gene Ontology
GO:0044165; C:host cell endoplasmic reticulum; IEA:UniProtKB-KW
GO:0044186; C:host cell lipid particle; IEA:UniProtKB-KW
GO:0033650; C:host cell mitochondrion; IEA:UniProtKB-KW
GO:0042025; C:host cell nucleus; IEA:UniProtKB-KW
GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-KW
GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW
GO:0044385; C:integral to membrane of host cell; IEA:UniProtKB-KW
GO:0030529; C:ribonucleoprotein complex; IEA:UniProtKB-KW
GO:0019031; C:viral envelope; IEA:UniProtKB-KW
GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW
GO:0005524; F:ATP binding; IEA:UniProtKB-KW
GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro
GO:0005216; F:ion channel activity; IEA:UniProtKB-KW
GO:0003723; F:RNA binding; IEA:UniProtKB-KW
GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW
GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro
GO:0005198; F:structural molecule activity; IEA:InterPro
GO:0008270; F:zinc ion binding; IEA:InterPro
GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
GO:0075512; P:clathrin-mediated endocytosis of virus by host cell; IEA:UniProtKB-KW
GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-KW
GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW
GO:0039645; P:modulation by virus of host G1/S transition checkpoint; IEA:UniProtKB-KW
GO:0039707; P:pore formation by virus in membrane of host cell; IEA:UniProtKB-KW
GO:0051259; P:protein oligomerization; IEA:UniProtKB-KW
GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
GO:0039545; P:suppression by virus of host MAVS activity; IEA:UniProtKB-KW
GO:0039563; P:suppression by virus of host STAT1 activity; IEA:UniProtKB-KW
GO:0039547; P:suppression by virus of host TRAF activity; IEA:UniProtKB-KW
GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW
GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
GO:0019087; P:transformation of host cell by virus; IEA:InterPro
GO:0039694; P:viral RNA genome replication; IEA:InterPro
GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW
Interpro
InterPro; IPR011492; DEAD_Flavivir
InterPro; IPR002521; HCV_core_C
InterPro; IPR002522; HCV_core_N
InterPro; IPR002519; HCV_env
InterPro; IPR002531; HCV_NS1
InterPro; IPR002518; HCV_NS2
InterPro; IPR000745; HCV_NS4a
InterPro; IPR001490; HCV_NS4b
InterPro; IPR002868; HCV_NS5a
InterPro; IPR013193; HCV_NS5a_1B_dom
InterPro; IPR024350; HCV_NS5a_C
InterPro; IPR014001; Helicase_ATP-bd
InterPro; IPR001650; Helicase_C
InterPro; IPR013192; NS5A_1a
InterPro; IPR027417; P-loop_NTPase
InterPro; IPR004109; Peptidase_S29
InterPro; IPR007094; RNA-dir_pol_PSvirus
InterPro; IPR002166; RNA_pol_HCV
InterPro; IPR009003; Trypsin-like_Pept_dom
Pfam
Pfam; PF07652; Flavi_DEAD;
Pfam; PF01543; HCV_capsid;
Pfam; PF01542; HCV_core;
Pfam; PF01539; HCV_env;
Pfam; PF01560; HCV_NS1;
Pfam; PF01538; HCV_NS2;
Pfam; PF01006; HCV_NS4a;
Pfam; PF01001; HCV_NS4b;
Pfam; PF01506; HCV_NS5a;
Pfam; PF08300; HCV_NS5a_1a;
Pfam; PF08301; HCV_NS5a_1b;
Pfam; PF12941; HCV_NS5a_C;
Pfam; PF02907; Peptidase_S29;
Pfam; PF00998; RdRP_3;
SMART
SMART; SM00487; DEXDc;
PROSITE
PROSITE; PS51693; HCV_NS2_PRO;
PROSITE; PS51192; HELICASE_ATP_BIND_1;
PROSITE; PS50507; RDRP_SSRNA_POS;
PRINTS